Lee WR - Search Results

1

Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.

Clark PE, Hall MC, Borden LS Jr, Miller AA, Hu JJ, Lee WR, Stindt D, D'Agostino R Jr, Lovato J, Harmon M, Torti FM. Clark PE, et al. Among authors: lee wr. Urology. 2006 Jun;67(6):1257-61. doi: 10.1016/j.urology.2005.12.035. Urology. 2006. PMID: 16765186 Clinical Trial.

2

Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation.

Hanks GE, Hanlon A, Schultheiss T, Corn B, Shipley WU, Lee WR. Hanks GE, et al. Among authors: lee wr. J Urol. 1994 Nov;152(5 Pt 2):1775-80. doi: 10.1016/s0022-5347(17)32384-4. J Urol. 1994. PMID: 7523724 Clinical Trial.

3

Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance?

Corn BW, Hanks GE, Lee WR, Schultheiss T. Corn BW, et al. Among authors: lee wr. Urology. 1995 Mar;45(3):484-9, discussion489-90. doi: 10.1016/s0090-4295(99)80020-x. Urology. 1995. PMID: 7533460

4

Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy.

Corn BW, Hanks GE, Lee WR, Bonin SR, Hudes G, Schultheiss T. Corn BW, et al. Among authors: lee wr. J Urol. 1995 Jun;153(6):1855-9. J Urol. 1995. PMID: 7538598

5

Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation.

Hanks GE, Lee WR, Schultheiss TE. Hanks GE, et al. Among authors: lee wr. J Urol. 1995 Aug;154(2 Pt 1):456-9. doi: 10.1097/00005392-199508000-00032. J Urol. 1995. PMID: 7541863 Clinical Trial.

6

Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone?

Lee WR, Hanlon A, Hanks GE. Lee WR, et al. Urology. 1996 May;47(5):704-7. doi: 10.1016/s0090-4295(96)00015-5. Urology. 1996. PMID: 8650869 Clinical Trial.

7

Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival.

Lee WR, Hanlon AL, Hanks GE. Lee WR, et al. J Urol. 1996 Aug;156(2 Pt 1):450-3. doi: 10.1097/00005392-199608000-00033. J Urol. 1996. PMID: 8683700

8

Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer.

Lee WR, Schultheiss TE, Hanlon AL, Hanks GE. Lee WR, et al. Urology. 1996 Jul;48(1):95-9. doi: 10.1016/s0090-4295(96)00085-4. Urology. 1996. PMID: 8693660

9

Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.

Lee WR, McQuellon RP, Case LD, deGuzman AF, McCullough DL. Lee WR, et al. J Urol. 1999 Aug;162(2):403-6. J Urol. 1999. PMID: 10411047 Clinical Trial.

10

Recent advances in the treatment of prostate cancer.

Kuyu H, Lee WR, Bare R, Hall MC, Torti FM. Kuyu H, et al. Among authors: lee wr. Ann Oncol. 1999 Aug;10(8):891-8. doi: 10.1023/a:1008385607847. Ann Oncol. 1999. PMID: 10509148 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

927 results

Search Page

Filters